Загрузка...
Montelukast for bronchiolitis obliterans syndrome after lung transplantation: A randomized controlled trial
Bronchiolitis obliterans syndrome (BOS) remains the major problem which precludes long-term survival after lung transplantation. Previously, an open label pilot study from our group demonstrated a possible beneficial effect of montelukast in progressive BOS patients with low airway neutrophilia (<...
Сохранить в:
| Опубликовано в: : | PLoS One |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Public Library of Science
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5889063/ https://ncbi.nlm.nih.gov/pubmed/29624575 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0193564 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|